» Articles » PMID: 10698505

HoxA9-mediated Immortalization of Myeloid Progenitors Requires Functional Interactions with TALE Cofactors Pbx and Meis

Overview
Journal Oncogene
Date 2000 Mar 4
PMID 10698505
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Specific Hox genes are implicated in leukemic transformation, and their selective genetic collaboration with TALE homeobox genes, Pbx and Meis, accentuates their oncogenic potential. The molecular mechanisms underlying these coordinate functions, however, have not been characterized. In this study, we demonstrate that HoxA9 requires its Pbx interaction motif as well as its amino terminus to enhance the clonogenic potential of myeloid progenitors in vitro. We further show that HoxA9 forms functional trimeric DNA binding complexes with Pbx and Meis-like proteins on a modified enhancer. DNA binding complexes containing HoxA9 and TALE homeoproteins display cooperative transcriptional activity and are present in leukemic cells. Trimeric complex formation on its own, however, is not sufficient for HoxA9-mediated immortalization. Rather, structure-function analyses demonstrate that domains of HoxA9 which are necessary for cellular transformation are coincident with those required for trimer-mediated transcriptional activation. Furthermore, the amino terminus of HoxA9 provides essential transcriptional effector properties and its requirement for myeloid transformation can be functionally replaced by the VP16 activation domain. These data suggest that biochemical interactions between HoxA9 and TALE homeoproteins mediate cellular transformation in hematopoietic cells, and that their transcriptional activity in higher order DNA binding complexes provides a molecular basis for their collaborative roles in leukemogenesis.

Citing Articles

The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in larvae.

Johannessen J, Formica M, Haukeland A, Brathen N, Al Outa A, Aarsund M iScience. 2023; 26(10):107726.

PMID: 37720104 PMC: 10504488. DOI: 10.1016/j.isci.2023.107726.


HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia.

Agrawal-Singh S, Bagri J, Giotopoulos G, Azazi D, Horton S, Lopez C Blood. 2022; 141(14):1737-1754.

PMID: 36577137 PMC: 10113176. DOI: 10.1182/blood.2022016528.


Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential.

Tang L, Peng L, Tan C, Liu H, Chen P, Wang H Cancer Cell Int. 2022; 22(1):349.

PMID: 36376832 PMC: 9664671. DOI: 10.1186/s12935-022-02767-9.


Regulation of chromatin accessibility by the histone chaperone CAF-1 sustains lineage fidelity.

Franklin R, Guo Y, He S, Chen M, Ji F, Zhou X Nat Commun. 2022; 13(1):2350.

PMID: 35487911 PMC: 9054786. DOI: 10.1038/s41467-022-29730-6.


MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy.

Blasi F, Bruckmann C J Dev Biol. 2021; 9(4).

PMID: 34698191 PMC: 8544432. DOI: 10.3390/jdb9040044.